MedPath

福建金山生物制药股份有限公司

Ownership
-
Established
1999-04-29
Employees
-
Market Cap
-
Website
http://www.chinajinshan.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Candesartan Cilexetil

Product Name
坎地沙坦酯
Approval Number
国药准字H20090131
Approval Date
Feb 6, 2025
NMPA

Mecobalamin

Product Name
甲钴胺
Approval Number
国药准字H20041226
Approval Date
Sep 24, 2015
NMPA

Thymopolypetides Injection

Product Name
胸腺肽注射液
Approval Number
国药准字H20003342
Approval Date
Oct 23, 2014
NMPA

Thymopolypetides Injection

Product Name
胸腺肽注射液
Approval Number
国药准字H20003343
Approval Date
Oct 23, 2014
NMPA

Flumazenil

Product Name
氟马西尼
Approval Number
国药准字H20065404
Approval Date
Jun 8, 2006
NMPA

Diazepam Injection

Product Name
地西泮注射液
Approval Number
国药准字H35020527
Approval Date
Jul 10, 2002
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.